查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1609835

2024-2032 年日本女性健康市場報告（按年齡層別類型、應用、配銷通路和地區）

Japan Women's Health Market Report by Age Group Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2023 年，日本女性IMARC Group市場規模達到 24.19 億美元。機器人輔助手術、微創手術和遠距醫療等醫療技術的不斷進步，改善了針對女性健康狀況的診斷和治療選擇，這主要推動了市場的發展。

女性健康是指女性一生中獨特的身體、心理和情緒健康。它涵蓋了廣泛的問題，包括生殖健康、性健康和整體身體健康。婦女健康的關鍵面向包括經期和更年期健康、懷孕和分娩、避孕、乳房健康和婦科護理。定期檢查、篩檢和獲得醫療保健對於維持女性健康至關重要。這包括子宮頸抹片檢查、乳房X光檢查和有關計劃生育的討論。心理健康也至關重要，因為女性更容易受到憂鬱和焦慮等疾病的影響。健康的生活方式，包括均衡飲食、規律運動和壓力管理，對女性健康起著重要作用。此外，促進性別平等並解決影響婦女健康的社會因素，例如歧視和獲得醫療保健的機會不平等，是確保婦女過上健康和充實生活的重要步驟。婦女健康是公共衛生的一個多面向且重要的方面，值得關注和支持。

日本女性保健市場趨勢：

日本的女性健康市場是多方面且相互關聯的，受到共同塑造女性醫療保健格局的各種因素的推動。首先，醫學研究和技術的進步極大地推動了女性健康市場的發展。乳房X光檢查和基因檢測等診斷工具的突破增強了乳癌和遺傳性疾病等疾病的早期發現，改善了整體健康。其次，對女性獨特醫療保健需求的認知不斷增強發揮了關鍵作用。婦女越來越了解預防保健的重要性，導致對婦科服務、避孕藥和產婦照護的需求更高。此外，社會變化，包括延遲生育和女性人口老化，也促進了該市場的擴張。這些轉變需要量身訂做的醫療保健解決方案，推動女性健康服務的創新和投資。此外，各種監管變化和政府措施透過多項政策改善了醫療保健的可近性，從而提高了婦女保健服務的可負擔性和可近性。預計這將在預測期內推動日本女性健康市場的發展。

日本女性健康市場細分：

年齡層類型見解：

50歲以上

  • 停經後骨質疏鬆症
  • 子宮內膜異位症和子宮肌瘤
  • 停經
  • 其他

應用見解：

  • 避孕藥具
  • 骨質疏鬆症
  • 停經
  • 不孕症
  • 其他

配銷通路見解：

  • 醫院藥房
  • 零售藥局
  • 網路藥局

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

  • 到目前為止，日本女性保健市場的表現如何，未來幾年將如何表現？
  • COVID-19 對日本女性保健市場有何影響？
  • 日本女性保健市場以年齡層類型分類是怎樣的？
  • 日本女性保健市場的應用基礎如何細分？
  • 日本女性保健品市場在配銷通路上的分化是怎麼樣的？
  • 日本女性保健市場價值鏈的各個階段是什麼？
  • 日本女性健康的關鍵促進因素和挑戰是什麼？
  • 日本女性保健市場的結構如何？
  • 日本女性保健品市場的競爭程度如何？

本報告回答的關鍵問題：

  • 到目前為止，日本女性保健市場的表現如何，未來幾年將如何表現？
  • COVID-19 對日本女性保健市場有何影響？
  • 日本女性保健市場以年齡層類型分類是怎樣的？
  • 日本女性保健市場的應用基礎如何細分？
  • 日本女性保健品市場在配銷通路上的分化是怎麼樣的？
  • 日本女性保健市場價值鏈的各個階段是什麼？
  • 日本女性健康的關鍵促進因素和挑戰是什麼？
  • 日本女性保健市場的結構如何？
  • 日本女性保健品市場的競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：日本女性健康市集 - 簡介

  • 概述
  • 市場動態
  • 產業動態
  • 競爭情報

第 5 章：日本女性保健市場格局

  • 歷史與當前市場趨勢（2018-2023）
  • 市場預測（2024-2032）

第 6 章：日本女性保健市場 - 細分：按年齡層類型

  • 50歲以上
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場區隔
      • 停經後骨質疏鬆症
      • 子宮內膜異位症和子宮肌瘤
      • 停經
    • 市場預測（2024-2032）
  • 其他
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）

第 7 章：日本女性保健市場 - 細分：按應用分類

  • 避孕藥具
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 骨質疏鬆症
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 停經
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 不孕症
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 其他
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）

第 8 章：日本女性保健市場 - 細分：按配銷通路

  • 醫院藥房
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 零售藥局
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）
  • 網路藥局
    • 概述
    • 歷史與當前市場趨勢（2018-2023）
    • 市場預測（2024-2032）

第 9 章：日本女性保健市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭儀表板
  • 公司評估象限

第 10 章：關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本女性保健市場 - 產業分析

  • 促進因素、限制因素和機會
    • 概述
    • 促進要素
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章：附錄

簡介目錄
Product Code: SR112024A18343

Japan women's health market size reached US$ 2,419.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,278.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.4% during 2024-2032. The increasing advances in medical technology, such as robotic-assisted surgery, minimally invasive procedures, and telemedicine, which have improved the diagnosis and treatment options available for women's health conditions, are primarily driving the market.

Women's health refers to the unique physical, mental, and emotional well-being of women across their lifespan. It encompasses a wide range of issues, including reproductive health, sexual health, and overall physical fitness. Key aspects of women's health include menstrual and menopausal health, pregnancy and childbirth, contraception, breast health, and gynecological care. Regular check-ups, screenings, and access to healthcare are essential to maintaining women's health. This includes Pap smears, mammograms, and discussions about family planning. Mental health is also crucial, as women are more susceptible to conditions like depression and anxiety. A healthy lifestyle, including a balanced diet, regular exercise, and stress management, plays a significant role in women's health. Additionally, promoting gender equality and addressing societal factors that affect women's health, such as discrimination and unequal access to healthcare, are essential steps toward ensuring that women can lead healthy and fulfilling lives. Women's health is a multifaceted and critical aspect of public health, deserving attention and support.

Japan Women's Health Market Trends:

The women's health market in Japan is multifaceted and interconnected, driven by various factors that collectively shape the landscape of healthcare for women. Firstly, advances in medical research and technology have significantly propelled the women's health market forward. Breakthroughs in diagnostic tools, such as mammography and genetic testing, have enhanced the early detection of diseases like breast cancer and hereditary conditions, improving overall health outcomes. Secondly, the growing awareness of women's unique healthcare needs has played a pivotal role. Women are increasingly informed about the importance of preventive care, leading to higher demand for gynecological services, contraceptives, and maternity care. Furthermore, societal shifts, including delayed childbirth and an aging female population, have contributed to the expansion of this market. These shifts require tailored healthcare solutions, driving innovation and investment in women's health services. Moreover, various regulatory changes and government initiatives improve access to healthcare through several policies, thereby enhancing the affordability and availability of women's health services. This, in turn, is expected to drive the women's health market in Japan during the forecast period.

Japan Women's Health Market Segmentation:

Age Group Type Insights:

50 Years and Above

  • Postmenopausal Osteoporosis
  • Endometriosis and Uterine Fibroids
  • Menopause
  • Others

Application Insights:

  • Contraceptives
  • Osteoporosis
  • Menopause
  • Infertility
  • Others

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan women's health market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan women's health market?
  • What is the breakup of the Japan women's health market on the basis of age group type?
  • What is the breakup of the Japan women's health market on the basis of application?
  • What is the breakup of the Japan women's health market on the basis of distribution channel?
  • What are the various stages in the value chain of the Japan women's health market?
  • What are the key driving factors and challenges in the Japan women's health?
  • What is the structure of the Japan women's health market and who are the key players?
  • What is the degree of competition in the Japan women's health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Women's Health Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Women's Health Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Women's Health Market - Breakup by Age Group Type

  • 6.1 50 Years and Above
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Postmenopausal Osteoporosis
      • 6.1.3.2 Endometriosis and Uterine Fibroids
      • 6.1.3.3 Menopause
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Others
    • 6.2.1 Historical and Current Market Trends (2018-2023)
    • 6.2.2 Market Forecast (2024-2032)

7 Japan Women's Health Market - Breakup by Application

  • 7.1 Contraceptives
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Osteoporosis
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Menopause
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Infertility
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2018-2023)
    • 7.5.2 Market Forecast (2024-2032)

8 Japan Women's Health Market - Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Retail Pharmacies
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Online Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)

9 Japan Women's Health Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Women's Health Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix